Interferon-stimulated genes and their protein products: What and how?

Journal of Interferon and Cytokine Research

Volumn 31, Issue 1, 2011, Pages 1-4

  Borden, Ernest C ^a   Williams, Bryan R ^b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN ISG15; PROTEIN KINASE R; STAT1 PROTEIN; STAT2 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INTERFERON STIMULATED GENE; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN TRANSPORT; REGULATOR GENE; REVIEW; RNA EDITING; RNA STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSLATION REGULATION; UPREGULATION;

ANIMALS; ANNIVERSARIES AND SPECIAL EVENTS; DRUG APPROVAL; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; RECOMBINANT PROTEINS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 78651506340     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0129     Document Type: Review

References (36)

1. Andrew A, Strebel K. 2010. The interferon-inducible host factor BST-2/tetherin restricts virion release; but is it actually a viral restriction factor? J Interferon Cytokine Res 31(1):137-144.
2. Borden EC, Jacobs B, Hollovary, Rybicki L, Elson P, Olencki T, Triozzi P. 2010. Gene regulatory and clinical effects of interferon (IFN) beta in patients with metastatic melanoma: a phase II trial. J Interferon Cytokine Res (In press) doi: 10.1089/ jir.2010.0054.
3. Chakrabarti A, Jha BK, Silverman RH. 2010. New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res 31(1):49-57.
4. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8(3):237-249.
5. Cheon H, Yang J, Stark GR. 2010. The functions of STATs 1 and 3 as cytokine-inducible proteins. J Interferon Cytokine Res 31(1):33-40.
6. Cheriyath V, Leaman DW, Borden EC. 2010. Emerging roles of FAM14 family members (G1P3/ISG 6-16 and ISG12/IFI27) in innate immunity and cancer. J Interferon Cytokine Res 31(1):173-181.
7. Das SK, Sokhi UK, Bhutia SK, Azab B, Su ZZ, Sarkar D, Fisher PB. 2010. Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells. Proc Natl Acad Sci U S A 107(26):11948-11953
8. Dong B, Zhou Q, Zhao J, Zhou A, Harty RN, Bose S, Banerjee A, Slee R, Guenther J, Williams BR, Wiedmer T, Sims PJ, Silverman RH. 2004. Phospholipid scramblase 1 potentiates the antiviral activity of interferon. J Virol 78(17):8983-8993.
9. Espert L, Degols G, Gongora C, Blondel D, Williams BR, Silverman RH, Mechti N. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J Biol Chem 278(18):16151-16158.
10. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, Trumpp A. 2009. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458(7240):904-908.
11. Fensterl V, Sen GC. 2010. The ISG56/IFIT1 gene family. J Interferon Cytokine Res 31(1):71-78.
12. Fitzgerald KA. 2010. The interferon inducible gene; viperin. J Interferon Cytokine Res 31(1):131-135.
13. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR. 1984. Transcriptional and posttranscriptional regulation of interferoninduced gene expression in human cells. Cell 38(3):745-755.
14. Gariglio M, Mondini M, De Andrea M, Landolfo S. 2010. The multifaceted interferon-inducible p200 family proteins: from cell biology to human pathology. J Interferon Cytokine Res 31(1):159-172.
15. Geoffroy MC, Chelbi-Alix MK. 2010. Role of PML in host antiviral defense. J Interferon Cytokine Res 31(1):145-158.
16. George CX, Gan Z, Liu Y, Samuel CE. 2010. Adenosine deaminases acting on RNA (ADARs), RNA editing and interferon action. J Interferon Cytokine Res 31(1):99-117.
17. Haller O, Kochs G. 2010. Human MxA protein: an interferoninduced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31(1):79-87.
18. Hertzog P, Forster S, Samarajiwa S. 2011. Systems biology of interferon responses. J Interferon Cytokine Res 31(1):5-11.
19. Khoo JJ, Forster S, Mansell A. 2010. Toll-like receptors as interferon regulated genes and their role in disease. J Interferon Cytokine Res 31(1):13-25.
20. Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R. 2010. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res 31(1):41-47.
21. Luszczek W, Cheriyath V, Mekhail TM, Borden EC. 2010. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression. Mol Cancer Ther 9(8):2309-2321.
22. Onoguchi K, Yoneyama M, Fujita T. 2010. RIG-I-like receptors. J Interferon Cytokine Res 31(1):27-31.
23. Park N, Katikaneni P, Skern T, Gustin KE. 2008. Differential targeting of nuclear pore complex proteins in poliovirusinfected cells. J Virol 82(4):1647-1655.
24. Pindel A, Sadler A. 2010. The role of PKR in the interferon response. J Interferon Cytokine Res 31(1):59-70.
25. Rani MR, Xu Y, Lee JC, Shrock J, Josyula A, Schlaak J, Chakraborthy S, Ja N, Ransohoff RM, Rudick RA. 2009. Heterogeneous, longitudinally stable molecular signatures in response to interferon-beta. Ann N Y Acad Sci 1182:58-68.
26. Ray PS, Jia J, Yao P, Majumder M, Hatzoglou M, Fox PL. 2009. A stress-responsive RNA switch regulates VEGFA expression. Nature 457(7231):915-919.
27. Siegrist F, Ebeling M, Certa U. 2010. The small interferon induced transmembrane genes and proteins: IFITM. J Interferon Cytokine Res 31(1):183-197.
28. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227-264.
29. Tamura T, Yanai H, Savitsky D, Taniguchi T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26:535-584.
30. Taylor KL, Leaman DW, Grane R, Mechti N, Borden EC, Lindner DJ. 2008. Identification of interferon-beta-stimulated genes that inhibit angiogenesis in vitro. J Interferon Cytokine Res 28(12):733-740.
31. Vestal DJ, Jeyaratnam JA. 2010. The guanylate-binding proteins (GBPs): emerging insights into the biochemical properties and functions of this family of large interferon-induced GTPases. J Interferon Cytokine Res 31(1):89-97.
32. Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DS, Baker SW, Khodarev N, Su AW, Shaikh AY, Roach P, Kreike B, Roizman B, Bergh J, Pawitan Y, van de Vijver MJ, Minn AJ. 2008. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci U S A 105(47): 18490-18495.
33. Xu D, Holko M, Sadler AJ, Scott B, Higashiyama S, Berkofsky- Fessler W, McConnell MJ, Pandolfi PP, Licht JD, Williams BR. 2009. Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity. Immunity 30(6): 802-816.
34. Yurkovetsky ZR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatnaya L, Winans MT, Gorelik E, Lokshin AE. 2007. Multiplex analysis of serum cytokines in melanoma patients treatedwith interferon-alpha2b. Clin Cancer Res 13(8):2422-2428.
35. Zhang D, Zhang D-E. 2010. ISG15 and the protein ISGylation system. J Interferon Cytokine Res 31(1):119-130.
36. Zimmerer JM, Lesinski GB, Ruppert AS, Radmacher MD, Noble C, Kendra K, Walker MJ, Carson WE 3rd. 2008. Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha. Clin Cancer Res 14(18):5900-5906.